IMM-H007, a new therapeutic candidate for nonalcoholic fatty liver disease, improves hepatic steatosis in hamsters fed a high-fat diet.

Shi, Huijie; Wang, Qingchun; Yang, Liu; Xie, Shouxia; Zhu, Haibo.

Affiliation

Shi H; State Key Laboratory of Bioactive Substance and Function of Natural Medicines Beijing Key Laboratory of New Drug Mechanisms and Pharmacological Evaluation Study Institute of Materia Medica Chinese Academy of Medical Sciences & Peking Union Medical College Beijing China.
Wang Q; Department of Pharmacology Shenzhen People's Hospital Second Clinical College Jinan University Shenzhen China.
Yang L; State Key Laboratory of Bioactive Substance and Function of Natural Medicines Beijing Key Laboratory of New Drug Mechanisms and Pharmacological Evaluation Study Institute of Materia Medica Chinese Academy of Medical Sciences & Peking Union Medical College Beijing China.
Xie S; State Key Laboratory of Bioactive Substance and Function of Natural Medicines Beijing Key Laboratory of New Drug Mechanisms and Pharmacological Evaluation Study Institute of Materia Medica Chinese Academy of Medical Sciences & Peking Union Medical College Beijing China.
Zhu H; Department of Pharmacology Shenzhen People's Hospital Second Clinical College Jinan University Shenzhen China.

FEBS Open Bio ; 7(9): 1379-1391, 2017 09.

Article in En | MEDLINE | ID: mdl-28904866